
Why Experts Advise, ‘Treat Anxiety As Your Best Ally, Not Your Enemy'
Most of us unwittingly fight or resist anxiety because it feels like an enemy, but mental health ... More experts advise that treating anxiety as your friend, instead of your enemy, helps reduce it.
You feel your heart pound during a job interview, quarterly review or presentation to colleagues. Butterflies swirl in your stomach before confronting the coworker who talks over you in meetings. And there's that knot in your chest and booming critical voice, lurking over your shoulder, making sure you get it right, as you pitch ideas to your team. While the physical and mental discomfort makes this a hard sell, mental health experts advise that if you start to treat your anxiety as a friend, instead as an enemy, it relaxes.
If you're like most people, you consider anxiety to be an enemy infiltrator that invades your mind and body. When it's sternly warning you--through headaches, indigestion, muscle spasms, body aches, clenched teeth or knots in your chest--you fight, ignore or try to stampede over it. These reactions add insult to injury, fueling the anxiety and exhausting you.
If you combat, fight or battle anxiety, it implies that anxiety is bad, something to get rid of. If you resist and react to anxiety--your bodyguard, your first responder-- it's like fighting the fire department when your house is on fire. It adds insult to injury, activates the sympathetic nervous system (your fight-or-flight response) and intensifies the emotion. Plus, it's exhausting and doesn't work.
Modern-day experts are advising that you befriend versus fight your anxiety. It's counterintuitive, but it's simple physics. Consider someone caught in a riptide. The life saving phrase 'Float Don't fight' was created to help swimmers survive rip currents. Fighting seems like the natural reaction, but it exhausts you and eventually drowns you. Floating parallel to the shore—going with the flow—brings you into dry land. Similarly, kayakers claim the best way to escape if you're trapped in a hydraulic—a turbulent funnel-shaped current—is to relax, and it will spit you out. But the tendency is to fight against the current, and that can keep you stuck, even drown you.
A similar course of action is a beginning point to reduce anxiety—going with it, instead of against it or responding instead of reacting to it. Although this is a hard pill to swallow, understanding that it's your friend, not your enemy, is the best medicine to manage and reduce it, and you can respond to it in a few simple steps.
'Why would I befriend something that is ruining my life?" you ask. This is a hard pill to swallow because it's counterintuitive, so the first step is to shift your perspective. It helps to think of your anxiety as a bodyguard or first responder. It has probably saved your life more times than you can count, and you might not even realize it. It's job is to keep you alert and aware, like an upset parent who swats her toddler, when he runs into busy traffic.
I spoke with psychotherapist Britt Frank, author of the new book, Align Your Mind. "Anxiety isn't the enemy—it's your internal smoke alarm,' she told me. 'Loud? Yes. But it's trying to keep you alive. We don't need to fight anxiety—that's like taking a jackhammer to your smoke alarm. The alarm isn't the problem—it's a signal pointing toward a problem.'
She explains that at its core, anxiety is your brain's way of scanning for threats and preparing you to act. "That heightened awareness, fast-beating heart and mental alertness?' Frank asks. 'Those are signs of a body ready to perform. When harnessed skillfully, anxiety can sharpen your focus, energize your body and give you the edge you need to rise to a challenge. Instead of seeing anxiety as a malfunction, see it as a superpower—one that needs guidance, not rejection.'
Accept it as normal, hardwired in you from birth for protection. Frank advises against thinking of anxiety as a disorder but to understand its true nature, which she describes as 'a finely tuned survival mechanism that's been keeping you alive since birth."
I also spoke with stress physiologist Dr. Rebecca Heiss, author of the groundbreaking new book SPRINGBOARD: Transform Stress to Work For You. Heiss also calls anxiety your Superpower, challenging conventional wisdom and suggesting that you frame stress and anxiety, not as an enemy, but as a powerful ally. She teaches that everybody is hardwired for anxiety and stress, and the only people who don't have it are dead.
Not to mention that anxiety makes us feel alive and thrive. Without anxiety, you wouldn't have as much fun. It gives you that thrill when you watch a suspenseful movie or root for your favorite Superbowl team. It provides excitement when you're on a roller coaster, bungee jumping, taking a safari, going to your first prom, getting married, buying your first house, delivering your firstborn, going through the haunted house at Halloween. I could go on and on, but you get the idea. Anxiety has gotten a bum rap.
Frank argues that the goal isn't to banish anxiety; it's to turn it into a high performance coach. You don't achieve by banning anxiety; you succeed when you harness it. That's how Simone Biles won Olympic gold, the Kansas City Chiefs the 2025 Superbowl and Meryl Streep snagged her string of Oscars. Without it, you might not be as successful in your career or your intimate and professional relationships could crumble. You would be more susceptible to danger, and your life could fall apart. And one thing's for sure: you wouldn't be alive right now.
The next time anxiety comes knocking, remind yourself that its function is to shield you. Then observe the emotion by self-distancing, much like inspecting a blemish on your hand. From a bird's-eye view, notice how it's doing its natural job, protecting you as it comes and goes. Frank suggests that, instead of reacting, that you respond to anxiety like a leader. Listen to it without letting it take the wheel, and when you feel it rising, pause and name it—'Here's my inner smoke alarm.'
Once you name it, neuroscience shows that self-talk can help you regulate it. Frank suggests, for example, that you engage in silent conversations with the anxious voice. When you hear it, say to that voice, 'I hear you. I've got this. I'll take it from here' to develop a non-combative relationship with it.
If possible, Frank recommends thanking your anxiety for trying to protect you, then take the lead with it. "Shift your mindset from 'How do I get rid of this?' to 'How can I use this energy?' Channel it into small, focused action—a 'Micro Yes' like writing one sentence, stretching or sending an email. This turns anxious energy into momentum. Over time, your brain learns: stress isn't the enemy; it's fuel. And with practice, you become the one steering the car, not the alarm in the passenger seat.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Bear Busts Through Nursing Home Window Before Being Lured Out with Rice Krispie Treats
Presbyterian Senior Living got an unusual visitor when a black bear burst through a window at the facility Staff lured it away with food after one person whacked it with a walker The Pennsylvania Game Commission safely captured and relocated the cubA nursing home in Pennsylvania had to evict an unwanted guest after a wild bear burst through their window looking for food. Staff and residents at Presbyterian Senior Living had a busy night on Tuesday, June 3 when a juvenile black bear broke through a window just after 11 p.m. One photo shared by CBS News Pittsburgh showed a shattered window, any showed claw marks by a different window sill. "I grabbed a walker and was hitting him, trying to get him away from the residents," Charlene Elliot told the news station exclusively during an on-camera interview. According to the nurse, her top priority was protecting the elderly residents: "Cause my thought was he was going to... maul them or swipe, slap at them.' 'That was my worst fear," she added. Elliot said her team did their best to get the bear out, using Rice Krispies Treats to lure the wild animal away from their Presbyterian Senior Living residents. Eventually their efforts worked, and they were able to get the animal out while keeping their residents safe. Pennsylvania Game Commission later arrived and set up a trap, which was able to humanely capture the approximately 150 pound cub and relocate it by Wednesday, June 4. Officials say of the estimated 18,000 black bears living in the state, most of them are generally afraid of humans and attacks rarely happen. The animals are typically just curious or looking for easy food. Elliot told the news station she was pleased with the work she did to keep her community safe. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. "I feel I went above and beyond for my residents and that's the way I feel. I would put my life on the line for them, and pretty much I did," the staffer said. "We are incredibly proud of our team's quick thinking and dedication to ensuring the safety of everyone in our community," Presbyterian Senior Living said in a news release, per CBS News Pittsburgh. "To prevent future wildlife encounters, the game warden safely relocated the bear to a more suitable habitat today and all bird feeders on our campus were removed." Read the original article on People


Health Line
an hour ago
- Health Line
Ask the Expert: Should I have Biomarker Testing – and Would it Help?
Biomarker testing in colorectal cancer can help assess inherited risk and identify characteristics that may influence the disease's growth, spread, and response to treatment. Colorectal cancer (CRC) starts in the colon or rectum of the large intestine. Your doctor may refer to it as 'colon cancer' or 'rectal cancer,' depending on where the cancer develops first, but both of these diagnoses are included under the banner of CRC. CRC is treatable, and biomarker testing is a part of precision medicine in your comprehensive treatment plan. Biomarker testing in CRC can help detect cancer in its earliest, most treatable stages. It can also provide important details about cancer after a diagnosis that influence treatment and outcomes. Dr. Smitha Krishnamurthi, a gastrointestinal oncology specialist with the Cleveland Clinic, talks with Healthline about biomarker testing and who it's recommended for. What is biomarker testing? Biomarker testing refers to testing of the colorectal cancer to find out if there are certain changes in the cancer's genes and proteins that could impact prognosis [outlook] and treatment. What are the most common biomarkers, and what do they show? Biomarkers in CRC measure a variety of different biological processes and states. Each biomarker provides important details about the cancer's growth, spread, or treatment response. DNA mismatch repair Hospital pathology labs now commonly test all initial biopsies or surgical specimens of colorectal cancer for the presence of DNA mismatch repair proteins. This is done via immunohistochemistry (IHC) staining of the slides to look for [the] expression of four mismatch repair proteins: MLH1, PMS2, MSH2, and MSH6. If one or two of these proteins are missing, then the cancer has deficient DNA mismatch repair. Microsatellite instability (MSI) This is a polymerase chain reaction (PCR) or next-generation sequencing (NGS) test [that looks] for abnormalities in microsatellite regions of the cancer DNA. The test can be done on a tumor specimen or blood (liquid biopsy). Microsatellites are short, repeated sequences of DNA. If the cancer has [atypical] DNA mismatch repair, errors will appear in microsatellite regions of DNA in the form of missing bases or extra bases added to the DNA sequence. RAS gene mutations (mutations in KRAS and NRAS genes) This testing can be performed by PCR or NGS testing of the tumor or NGS testing of blood (liquid biopsy). RAS is a very important oncogene, meaning that it is a gene that, when mutated, drives cancer cell proliferation and survival. Mutations in RAS genes are found in up to 50% of colorectal cancers. BRAF V600E gene mutation This testing can be performed by PCR or NGS testing of the tumor or NGS testing of blood (liquid biopsy). The BRAF V600E protein can also be detected by IHC. BRAF is another oncogene, so when it is mutated, it leads to cancer cell proliferation and survival. BRAF V600E mutations occur in about 8% to 10% of colorectal cancers and are more common in right-sided cancers. HER2 protein overexpression by IHC or gene amplification by NGS HER2 is another oncogene — gene amplification leads to [the] overexpression of the HER2 protein. Overexpression of HER2 leads to increased signaling via the epidermal growth factor receptor pathway, leading to cancer cell proliferation and survival. PIK3CA PIK3CA is another oncogene. Mutations in PIK3CA and a related gene, PIK3R1, lead to cancer cell proliferation and survival. Mutations in PIK3CA and PIK3R1 are typically found via NGS. PTEN PTEN is a tumor suppressor gene, [which typically] suppresses cancer growth. When the PTEN gene is mutated, the protein is not expressed, and that leads to [the] proliferation of cancer. PTEN gene mutations are typically found via NGS. Who should have biomarker testing done? All patients with colorectal cancer should have testing of their cancer for DNA mismatch repair (or microsatellite instability) soon after diagnosis. This is important for patients with cancers of all stages. Patients with early stage colorectal cancer should have testing of their cancers for mutations in PIK3CA, PTEN, and PIK3R1 by the time they finish adjuvant treatment or after surgery if [they're] not having adjuvant treatment. Patients with metastatic colorectal cancer should have next-generation sequencing of the cancer soon after diagnosis, as the results may impact the initial systemic treatment. The NGS results are also useful for identifying clinical trial eligibility. Comorbidities will not affect the results of these biomarkers, so they should not affect the timing and decision making about ordering these tests. How does biomarker testing help the treatment and outcome of a diagnosis? Biomarkers can impact your treatment choices and outcomes. They can help doctors decide which medications will be the most effective, identify inherited features in cancer, and determine if adjuvant or additional therapies would improve outcomes. Immunotherapy responsiveness It is critical to know if a cancer has deficient DNA mismatch repair (dMMR) or high microsatellite instability (MSI-H) because these cancers can respond dramatically to immunotherapy in the early stage and metastatic settings. For example, patients with rectal cancer that is dMMR or MSI-H may have a complete clinical response with immunotherapy and may be able to avoid radiation and surgery. Thus, this testing needs to be done early, before treatment starts. Identifying Lynch syndrome Another important reason for testing for dMMR or MSI-H is to identify cancers caused by Lynch syndrome. Lynch syndrome is the most common type of inherited colorectal cancer and is caused by germline mutations in the genes that code for the DNA mismatch repair proteins or in another related gene called EPCAM. Most cancers with deficient mismatch repair or MSI-H are not caused by Lynch syndrome and occur sporadically. We don't want to miss patients with Lynch syndrome, however, because they can benefit from counseling about [the] prevention of Lynch syndrome-related cancers such as uterine cancer, ovarian cancer, and gastric cancer, in addition to colorectal cancer. When a patient is diagnosed with Lynch syndrome, family members can then be tested to see if they have Lynch syndrome. Recommendations for cancer screening at early stages are made for individuals with Lynch syndrome, and early screening can be lifesaving. Identifying treatment resistance Mutations in KRAS and NRAS make cancers resistant to anti-epidermal growth factor receptor therapy. Cancers with KRAS G12C mutations can be treated with a regimen that targets this mutation (adagrasib plus cetuximab or sotorasib plus panitumumab). There are also many clinical trials now studying RAS gene inhibitors in patients with metastatic colorectal cancer that have been previously treated. Cancers with BRAF V600E tend to be aggressive and less sensitive to chemotherapy. There is a Food and Drug Administration (FDA)-approved regimen targeting BRAF V600E (encorafenib plus cetuximab) in metastatic colorectal cancer that improves survival when added to first-line FOLFOX chemotherapy. It also improves survival as a second-line treatment after chemotherapy. Greater response to targeted and adjuvant therapy Metastatic colorectal cancers that demonstrate [the] overexpression or gene amplification of HER2 can be treated with a targeted regimen of tucatinib plus trastuzumab after initial chemotherapy. Another targeted treatment available for metastatic colorectal cancers that overexpress HER2 by IHC is trastuzumab deruxtecan. Patients with early stage colorectal cancer with mutations in the PIK3CA, PIK3R1, or PTEN genes should be treated with aspirin 160 milligrams daily for 3 years after adjuvant therapy or after surgery if [they're] not having adjuvant therapy. The ALASCCA trial, presented at ASCO GI [American Society of Clinical Oncology – Gastrointestinal Cancer] in 2025, compared a placebo to aspirin in this patient population and found that aspirin significantly lowered the rate of cancer recurrence at 3 years. This is rather new data. Oncologists are starting to order NGS testing for patients with early stage cancers in order to obtain this biomarker information. What should you ask your doctor? It's always OK to ask your doctor about biomarker testing and what it means for you. Important questions to consider include: Is my cancer dMMR/MSI-H? Am I a candidate for immunotherapy? Patients with early stage colorectal cancer should ask if aspirin therapy will be recommended based on biomarker testing. Patients with metastatic colorectal cancer should ask for the results of RAS/BRAF/HER2 testing and overall NGS testing results.
Yahoo
an hour ago
- Yahoo
Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights
TeleTracking Technologies, a leading provider of healthcare operations platforms, has teamed up with Palantir Technologies Inc. (NASDAQ:PLTR), known for its expertise in artificial intelligence systems. The two companies have formed a strategic partnership with the goal of transforming how hospitals and health systems make operational decisions, ultimately creating long-term value for healthcare providers around the world. The collaboration will integrate TeleTracking's Operations IQ platform with Palantir Technologies Inc. (NASDAQ:PLTR)'s AI-driven tools, including Foundry and AIP. This combined solution is expected to equip hospitals with near real-time, actionable insights to improve staffing efficiency, speed up decision-making, and ensure that patient needs remain the top priority. As healthcare systems continue to face increasing demands to enhance capacity and coordination without expanding their physical footprint, this partnership represents a significant step forward. By bringing together TeleTracking's operational strengths and Palantir Technologies Inc. (NASDAQ:PLTR)'s cutting-edge technology, the two aim to usher in a new era of intelligent, scalable, and efficient healthcare delivery. Alex Karp, CEO at Palantir Technologies Inc. (NASDAQ:PLTR) made the following comment: 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach, helping to streamline operations allowing for increased focus on providing the best level of care.' Palantir Technologies Inc. (NASDAQ:PLTR) is an American publicly traded company that focuses on developing software platforms designed for analyzing large volumes of data. While we acknowledge the potential of PLTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data